Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Iouri Boiko is active.

Publication


Featured researches published by Iouri Boiko.


Journal of Biomedical Optics | 2001

Understanding the contributions of NADH and collagen to cervical tissue fluorescence spectra: modeling, measurements, and implications.

Rebekah A. Drezek; Konstantin Sokolov; Urs Utzinger; Iouri Boiko; Anais Malpica; Michele Follen; Rebecca Richards-Kortum

OBJECTIVE At 380 nm excitation, cervical tissue fluorescence spectra demonstrate characteristic changes with both patient age and the presence of dysplasia. A Monte Carlo model was developed in order to quantitatively examine how intrinsic NADH and collagen fluorescence, in combination with tissue scattering and absorption properties, yield measured tissue spectra. METHODS Excitation-emission matrices were measured for live cervical cells and collagen gel phantoms. Fluorescence microscopy of fresh tissue sections was performed to obtain the location and density of fluorophores as a function of patient age and the presence of dysplasia. A Monte Carlo model was developed which incorporated measurements of fluorophore line shapes and spatial distributions. RESULTS Modeled spectra were consistent with clinical measurements and indicate that an increase in NADH fluorescence and decrease in collagen fluorescence create clinically observed differences between normal and dysplastic tissue spectra. Model predictions were most sensitive to patient age and epithelial thickness. CONCLUSIONS Monte Carlo techniques provide an important means to investigate the combined contributions of multiple fluorophores to measured emission spectra. The approach will prove increasingly valuable as a more sophisticated understanding of in vivo optical properties is developed.


Journal of Biomedical Optics | 2003

Light scattering from cervical cells throughout neoplastic progression: influence of nuclear morphology, DNA content, and chromatin texture.

Rebekah A. Drezek; Martial Guillaud; Thomas G. Collier; Iouri Boiko; Anais Malpica; Calum MacAulay; Michele Follen; Rebecca Richards-Kortum

A number of noninvasive fiber optic optical technologies are under development for real-time diagnosis of neoplasia. We investigate how the light scattering properties of cervical cells are affected by changes in nuclear morphology, DNA content, and chromatin texture, which occur during neoplastic progression. We used a Cyto-Savant computer-assisted image analysis system to acquire quantitative nuclear features measurements from 122 Feulgen-thionin-stained histopathologic sections of cervical tissue. A subset of the measured nuclear features was incorporated into a finite-difference time-domain (FDTD) model of cellular light scattering. The magnitude and angular distribution of scattered light was calculated for cervical cells as a function of pathologic grade. The nuclear atypia strongly affected light scattering properties. The increased size and elevated DNA content of nuclei in high-grade lesions caused the most significant changes in scattering intensity. The spatial dimensions of chromatin texture features and the amplitude of refractive index fluctuations within the nucleus impacted both the angular distribution of scattering angles and the total amount of scattered light. Cellular scattering is sensitive to changes in nuclear morphology that accompany neoplastic progression. Understanding the quantitative relationships between nuclear features and scattering properties will aid in the development of noninvasive optical technologies for detection of precancerous conditions.


Photochemistry and Photobiology | 2001

Autofluorescence Microscopy of Fresh Cervical-Tissue Sections Reveals Alterations in Tissue Biochemistry with Dysplasia ¶

Rebekah A. Drezek; Carrie Brookner; Ina Pavlova; Iouri Boiko; Anais Malpica; Reuben Lotan; Michele Follen; Rebecca Richards-Kortum

Abstract Fluorescence spectroscopy offers an effective, noninvasive approach to the detection of precancers in multiple organ sites. Clinical studies have demonstrated that fluorescence spectroscopy can provide highly sensitive, specific and cost-effective diagnosis of cervical precancers. However, the underlying biochemical mechanisms responsible for differences in the fluorescence spectra of normal and dysplastic tissue are not fully understood. We designed a study to assess the differences in autofluorescence of normal and dysplastic cervical tissue. Transverse, fresh tissue sections were prepared from colposcopically normal and abnormal biopsies in a 34-patient study. Autofluorescence images were acquired at 380 and 460 nm excitation. Results showed statistically significant increases in epithelial fluorescence intensity (arbitrary units) at 380 nm excitation in dysplastic tissue (106 ± 39) relative to normal tissue (85 ± 30). The fluorophore responsible for this increase is possibly reduced nicotinamide adenine dinucleotide. Stromal fluorescence intensities in the dysplastic samples decreased at both 380 nm (102 ± 34 [dysplasia] vs 151 ± 44 [normal]) and 460 nm excitation (93 ± 35 [dysplasia] vs 137 ± 49 [normal]), wavelengths at which collagen is excited. Decreased redox ratio (17–40% reduction) in dysplastic tissue sections, indicative of increased metabolic activity, was observed in one-third of the paired samples. These results provide valuable insight into the biological basis of the differences in fluorescence of normal and precancerous cervical tissue.


Photochemistry and Photobiology | 2000

Autofluorescence Patterns in Short‐Term Cultures of Normal Cervical Tissue

Carrie Brookner; Michele Follen; Iouri Boiko; Javier Galvan; Sharon L. Thomsen; Anais Malpica; Seigo Suzuki; Reuben Lotan; Rebecca Richards-Kortum

Abstract Fluorescence spectroscopy has potential to improve cervical precancer detection. The relationship between tissue biochemistry and fluorescence is poorly understood. The goal of this study was to characterize normal cervical autofluorescence, using fresh tissue short-term tissue cultures and epithelial cell suspensions. Transverse, short-term tissue cultures were prepared from 31 cervical biopsies; autofluorescence images were obtained at 380 and 460 nm excitation. Fluorescence excitation–emission matrices were measured from normal, precancerous and cancerous cervical cell suspensions. Observed fluorescence patterns contrast those reported for frozen–thawed tissue, and were placed into groups with (1) bright epithelial and weak stromal fluorescence; (2) similar epithelial and stromal fluorescence; and (3) weak epithelial and bright stromal fluorescence. The average ages of women in the groups were 30.9, 38.0 and 49.2 years. Epithelial fluorescence intensity was similar in Groups 1 and 2, but weaker in Group 3. Stromal intensity was similar in Groups 2 and 3, but weaker in Group 1. The ratio of epithelial to stromal fluorescence intensity was significantly different for all groups. EEMs of cell suspensions showed peaks consistent with tryptophan, reduced form of nicotinamide adenine dinucleotide (phosphate) and flavin adenine dinucleotide. Short-term tissue cultures represent a novel, biologically appropriate model to understand cervical autofluorescence. Our results suggest a biological basis for the increased fluorescence seen in older, postmenopausal women.


Cytometry | 1999

NUCLEAR MORPHOMETRY AS AN INTERMEDIATE ENDPOINT BIOMARKER IN CHEMOPREVENTION OF CERVICAL CARCINOMA USING ALPHA -DIFLUOROMETHYLORNITHINE

Neal Poulin; Iouri Boiko; Calum MacAulay; Charles W. Boone; Kenji Nishioka; Walter N. Hittelman; Michele Follen Mitchell

The use of nuclear morphometry as an intermediate endpoint biomarker is described in a Phase I, dose-seeking trial of chemoprevention of cervical cancer, using the agent alpha-difluoromethylornithine (DFMO). Thirty patients with grade III cervical intraepithelial neoplasia (CIN III) were enrolled, and these received daily doses of DFMO at 0.06-1.0 mg/m(2) for a period of 1 month. Fifteen patients were observed to have a complete or partial regressive response to the agent, as assessed by histopathology. No significant differences in cell feature measurements were found between responders and nonresponders in specimens obtained before treatment, indicating that it may be difficult to predict response on the basis of these measurements. In specimens collected after treatment, large differences in morphometric features were observed between responders and nonresponders, indicating a differential effect of DFMO. Significantly modulated features were considered in terms of their correlations with CIN grade, which was determined from an independent set of measurements from archival tissue. Differences between features were consistent with a deletion of cells with high grade nuclei in the responders, and with the persistence of a more heterogeneous population of high grade cells in the nonresponders. Based on an independent set of measurements from archival material, a morphometric index of progression was derived, yielding a quantitative measure of the degree of nuclear atypia in these lesions. When applied to this trial, the morphometric index was seen to be specifically and consistently decreased in responsive lesions, and unchanged in nonresponders. The study indicates that morphometric features fulfill the requirements for an intermediate endpoint biomarker of cervical cancer chemoprevention.


Analytical Cellular Pathology | 2003

Use of Nuclear Morphometry Characteristics to Distinguish between Normal and Abnormal Cervical Glandular Histologies

Richard J. Swartz; Loyd A. West; Iouri Boiko; Anais Malpica; Calum MacAulay; Anita Carraro; Martial Guillaud; Dennis D. Cox; Michele Follen

This is a methodological study exploring the use of quantitative histopathology applied to the cervix to discriminate between normal and cancerous (consisting of adenocarcinoma and adenocarcinoma in situ) tissue samples. The goal is classifying tissue samples, which are populations of cells, from measurements on the cells. Our method uses one particular feature, the IODs‐Index, to create a tissue level feature. The specific goal of this study is to find a threshold for the IODs‐Index that is used to create the tissue level feature. The main statistical tool is Receiver Operating Characteristic (ROC) curve analysis. When applied to the data, our method achieved promising results with good estimated sensitivity and specificity for our data set. The optimal threshold for the IODs‐Index was found to be 2.12.


Biomedical Optical Spectroscopy and Diagnostics (2000), paper MC2 | 2000

Biological basis of cervical tissue autofluorescence

Rebecca Richards-Kortum; Carrie Brookner; Iouri Boiko; Anais Malpica; Sharon L. Thomsen; Reuben Lotan; Michele Follen

The goal of this study was to characterize the biological basis of cervical autofluorescence. Fluorescence of transverse fresh tissue slices was imaged using a fluorescence microscope. Fluorescence spectra were measured from cervical epithelial cell suspensions.


American Journal of Obstetrics and Gynecology | 2005

Optical coherence tomography: a pilot study of a new imaging technique for noninvasive examination of cervical tissue.

Andres Zuluaga; Michele Follen; Iouri Boiko; Anais Malpica; Rebecca Richards-Kortum


Cancer Epidemiology, Biomarkers & Prevention | 2001

Quantitative Nuclear Morphometry by Image Analysis for Prediction of Recurrence of Ductal Carcinoma in Situ of the Breast

Ashraful Hoque; Scott M. Lippman; Iouri Boiko; Edward N. Atkinson; Nour Sneige; Aysegul A. Sahin; Diane M. Weber; Seymon Risin; Michael D. Lagios; Roland Schwarting; William J. Colburn; Kapil Dhingra; Michele Follen; Gary J. Kelloff; Charles W. Boone; Walter N. Hittelman


Clinical Cancer Research | 2005

Results of a Phase II Double-Blinded Randomized Clinical Trial of Difluoromethylornithine for Cervical Intraepithelial Neoplasia Grades 2 to 3

Anne Therese Vlastos; Loyd A. West; E. Neely Atkinson; Iouri Boiko; Anais Malpica; Waun Ki Hong; Michele Follen

Collaboration


Dive into the Iouri Boiko's collaboration.

Top Co-Authors

Avatar

Anais Malpica

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Michele Follen

Brookdale University Hospital and Medical Center

View shared research outputs
Top Co-Authors

Avatar

Walter N. Hittelman

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Calum MacAulay

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

E. Neely Atkinson

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Loyd A. West

Naval Medical Center Portsmouth

View shared research outputs
Top Co-Authors

Avatar

Michele Follen Mitchell

University of Texas MD Anderson Cancer Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge